ASSOCIATION BETWEEN VISCERAL FAT, LIPID PEROXIDATION, AND ANTIOXIDANT STATUS IN PREDIABETIC INDIVIDUALS

Main Article Content

Bhaskara Rao Motamarri
Jaya Jain
Ashutosh Jain

Keywords

Prediabetes, Visceral adiposity, Oxidative stress, , Antioxidant status, Redox ratio

Abstract

Background: Prediabetes, which is often linked to central adiposity and oxidative stress, is a high-risk state for the development of type 2 diabetes and cardiovascular disease. This study aimed to assess the relationship between oxidative stress indicators and visceral adiposity in prediabetic individuals in comparison to normoglycemic controls.


Methods: A cross-sectional case-control study was carried out on 96 people with prediabetes and 96 controls who were matched for age and sex. Malondialdehyde [MDA], total antioxidant status [TAOS], and redox ratio [RR] were biochemical indicators of oxidative stress, and anthropometric measures (height, weight, BMI, waist circumference, hip circumference, waist-to-hip ratio, and visceral fat percentage) were examined. Pearson's correlation was used to evaluate the relationships between visceral fat and biochemical markers, and independent two-sample t-tests were used to examine differences between groups.


Results: Participants with prediabetes had significantly higher visceral fat percentage (t = –13.39, p < 0.0001), waist circumference (t = –3.29, p = 0.0012), waist-to-hip ratio (t = –3.06, p = 0.0025), and BMI (t = –3.95, p < 0.001) than controls. The prediabetic group had significantly lower TAOS (t = 39.82, p < 0.0001) and higher MDA (t = –10.71, p < 0.0001) and RR (t = 51.89, p < 0.0001), according to biochemical tests. Visceral fat had a negative correlation with TAOS (r = –0.676, p < 0.001) and RR (r = –0.683, p < 0.001) and a positive correlation with MDA (r = 0.590, p < 0.001).


Conclusion: The manifestations of prediabetes include increased lipid peroxidation, decreased antioxidant defense, and increased visceral adiposity. A major molecular element in the progression from prediabetes to overt diabetes is central obesity, as seen by the substantial associations found between visceral fat and redox imbalance. Effective preventive measures could include focusing on oxidative stress reduction and visceral fat reduction.

Abstract 20 | PDF Downloads 6

References

[1] Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract 2018;138:271–81. https://doi.org/10.1016/j.diabres.2018.02.023.
[2] Federation ID, Atlas IDFD. International daibetes federation 2021. IDF Diabetes Atlas 2021.
[3] Tabák AG, Herder C, Rathmann W, Brunner EJ, Kivimäki M. Prediabetes: a high-risk state for diabetes development. Lancet 2012;379:2279–90. https://doi.org/10.1016/S0140-6736(12)60283-9.
[4] Després J-P. Body Fat Distribution and Risk of Cardiovascular Disease. Circulation 2012;126:1301–13. https://doi.org/10.1161/CIRCULATIONAHA.111.067264.
[5] Neeland IJ, Ross R, Després J-P, Matsuzawa Y, Yamashita S, Shai I, et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabetes Endocrinol 2019;7:715–25. https://doi.org/10.1016/S2213-8587(19)30084-1.
[6] Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu C-Y, et al. Abdominal Visceral and Subcutaneous Adipose Tissue Compartments. Circulation 2007;116:39–48. https://doi.org/10.1161/CIRCULATIONAHA.106.675355.
[7] Houstis N, Rosen ED, Lander ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006;440:944–8. https://doi.org/10.1038/nature04634.
[8] Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006;444:860–7. https://doi.org/10.1038/nature05485.
[9] Pickup JC. Inflammation and Activated Innate Immunity in the Pathogenesis of Type 2 Diabetes. Diabetes Care 2004;27:813–23. https://doi.org/10.2337/diacare.27.3.813.
[10] Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes. Endocr Rev 2002;23:599–622. https://doi.org/10.1210/er.2001-0039.
[11] Giacco F, Brownlee M. Oxidative Stress and Diabetic Complications. Circ Res 2010;107:1058–70. https://doi.org/10.1161/CIRCRESAHA.110.223545.
[12] Ceriello A, Motz E. Is Oxidative Stress the Pathogenic Mechanism Underlying Insulin Resistance, Diabetes, and Cardiovascular Disease? The Common Soil Hypothesis Revisited. Arterioscler Thromb Vasc Biol 2004;24:816–23. https://doi.org/10.1161/01.ATV.0000122852.22604.78.
[13] Pitocco D, Tesauro M, Alessandro R, Ghirlanda G, Cardillo C. Oxidative Stress in Diabetes: Implications for Vascular and Other Complications. Int J Mol Sci 2013;14:21525–50. https://doi.org/10.3390/ijms141121525.
[14] Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004;114:1752–61. https://doi.org/10.1172/JCI21625.
[15] Couillard C, Ruel G, Archer WR, Pomerleau S, Bergeron J, Couture P, et al. Circulating Levels of Oxidative Stress Markers and Endothelial Adhesion Molecules in Men with Abdominal Obesity. J Clin Endocrinol Metab 2005;90:6454–9. https://doi.org/10.1210/jc.2004-2438.
[16] Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006;444:840–6. https://doi.org/10.1038/nature05482.
[17] Klisić A, Radoman Vujačić I, Kostadinović J, Patoulias D, Ninić A. Novel anthropometric parameters in the adult population with prediabetes. Eur Rev Med Pharmacol Sci 2023;27:11063–72. https://doi.org/https://doi.org/10.26355/eurrev_202311_34475.
[18] Jayedi A, Soltani S, Motlagh SZ, Emadi A, Shahinfar H, Moosavi H, et al. Anthropometric and adiposity indicators and risk of type 2 diabetes: systematic review and dose-response meta-analysis of cohort studies. BMJ 2022:e067516. https://doi.org/10.1136/bmj-2021-067516.
[19] Rains JL, Jain SK. Oxidative stress, insulin signaling, and diabetes. Free Radic Biol Med 2011;50:567–75. https://doi.org/10.1016/j.freeradbiomed.2010.12.006.
[20] Folli F, Corradi D, Fanti P, Davalli A, Paez A, Giaccari A, et al. The Role of Oxidative Stress in the Pathogenesis of Type 2 Diabetes Mellitus Micro- and Macrovascular Complications: Avenues for a Mechanistic-Based Therapeutic Approach. Curr Diabetes Rev 2011;7:313–24. https://doi.org/10.2174/157339911797415585.
[21] Ghasemi-Dehnoo M, Amini-Khoei H, Lorigooini Z, Rafieian-Kopaei M. Oxidative stress and antioxidants in diabetes mellitus. Asian Pac J Trop Med 2020;13:431. https://doi.org/10.4103 /1995-7645.291036.
[22] Pou KM, Massaro JM, Hoffmann U, Vasan RS, Maurovich-Horvat P, Larson MG, et al. Visceral and Subcutaneous Adipose Tissue Volumes Are Cross-Sectionally Related to Markers of Inflammation and Oxidative Stress. Circulation 2007;116:1234–41. https://doi.org/10.1161/ CIRCULATIONAHA.107.710509.
[23] García-Sánchez A, Gámez-Nava JI, Díaz-de la Cruz EN, Cardona-Muñoz EG, Becerra-Alvarado IN, Aceves-Aceves JA, et al. The Effect of Visceral Abdominal Fat Volume on Oxidative Stress and Proinflammatory Cytokines in Subjects with Normal Weight, Overweight and Obesity. Diabetes, Metab Syndr Obes Targets Ther 2020;Volume 13:1077–87. https://doi.org/10.2147/ DMSO.S245494.